Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 130/0.4 vs Ringer lactate to prevent hypotension during spinal anaesthesia for caesarean section
2007-006065-32Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Jan 2008
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of Volulyte in hypotension (2 arms), sponsored by Fresenius Kabi. Primary endpoint: Incidence of hypotension between induction of spinal anaesthesia and delivery. Started Jan 2008; status: completed.
02
Drugs
Volulyte
03
Conditions
hypotension
Beyond the preview
Go deeper on 2007-006065-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006065-32.